1. Psychiatric disorders in patients with cerebrotendinous xanthomatosis;Berginer, V.M.; Foster, N.L.; Sadowsky, M.; Townsend, J.A.; Siegel, G.J.; Salen, G.;Am J Psychiatry,1988
2. Peripheral neuropathy in cerebrotendinous xanthomatosis;Kuritzky, A.; Berginer, V.M.; Korczyn, A.D.;Neurology,1979
3. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis;Salen, G.; Berginer, V.; Shore, V.; Horak, I.; Horak, E.; Tint, G.S.; Shefer, S.;N Engl J Med,1987
4. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid;Pedley, T.A.; Emerson, R.G.; Warner, C.L.; Rowland, L.P.; Salen, G.;Ann Neurol,1985
5. The metabolism of cholestanol, cholesterol and bile acids in cerebrotendinous xanthomatosis;Salen, G.; Grundy, S.M.;J Clin Invest,1973